Related Experiment Video
Updated: May 30, 2026

Social Defeat Stress Model for Adolescent C57BL/6 Male and Female Mice
Published on: March 15, 2024
Suicidality and depression disparities between sexual minority and heterosexual youth: a meta-analytic review
Michael P Marshal1, Laura J Dietz, Mark S Friedman
1Center for Research on Health and Sexual Orientation, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA 15213, USA. marshalmp@upmc.edu
Purpose:
To examine disparities between sexual minority youth (SMY) and heterosexual youth in rates of suicidality and depression symptoms.
Methods:
Separate meta-analyses were conducted to examine suicidality and depression disparities. Studies were included if the average age of the participants was <18 years, and if suicidality or depression symptoms were compared across SMY and heterosexual youth.
Results:
SMY reported significantly higher rates of suicidality (odds ratio [OR] = 2.92) and depression symptoms (standardized mean difference, d = .33) as compared with the heterosexual youth. Disparities increased with the increase in the severity of suicidality (ideation [OR = 1.96], intent/plans [OR = 2.20], suicide attempts [OR = 3.18], suicide attempts requiring medical attention [OR = 4.17]). Effects did not vary across gender, recruitment source, and sexual orientation definition.
Conclusions:
Disparities in suicidality and depression may be influenced by negative experiences including discrimination and victimization. Clinicians should assess sexual orientation, analyze psychosocial histories to identify associated risk factors, and promote prevention and intervention opportunities for SMY and their families.
Related Concept Videos
Ethnic Identity within a Larger Culture
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Self-Discrepancy and Its Effects
Amebiasis
Depressive Disorders: MDD and Dysthymia
Antidepressant Drugs: MAOIs and Other Agents
